Hyderabad Telangana, India

Ashok Chennaveerappa Bajji


Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Ashok Chennaveerappa Bajji

Introduction

Ashok Chennaveerappa Bajji is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for the treatment of diabetes and dyslipidemia. With a total of two patents to his name, his work reflects a commitment to advancing medical science.

Latest Patents

His latest patents include innovative compounds known as Azolidinediones, which are useful for treating diabetes and dyslipidemia. These patents describe a compound of formula (I) along with its tautomeric forms, stereoisomers, polymorphs, and pharmaceutically acceptable salts or solvates. The compounds are characterized by various substituents, including aromatic cyclic structures and heteroatoms, which enhance their therapeutic potential. Additionally, he has developed novel antidiabetic compounds, their derivatives, and methods for preparing these compounds, showcasing his expertise in medicinal chemistry.

Career Highlights

Throughout his career, Ashok has worked with reputable organizations such as Reddy-Cheminor, Inc. and Dr. Reddy's Research Foundation. His experience in these companies has allowed him to collaborate on various research projects, contributing to the advancement of pharmaceutical sciences.

Collaborations

Some of his notable coworkers include Braj Bhushan Lohray and Vidya Bhushan Lohray. Their collaborative efforts have likely played a role in the successful development of innovative pharmaceutical solutions.

Conclusion

Ashok Chennaveerappa Bajji's contributions to the field of pharmaceuticals through his patents and collaborations highlight his dedication to improving healthcare. His work continues to influence the treatment of diabetes and related conditions, making a significant impact in the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…